{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:44:18Z","timestamp":1786981458105,"version":"build-2736575974"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11468-8","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T13:15:05Z","timestamp":1769174105000},"page":"4927-4948","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Recent advances in carbonyl infused bis-pyrazoles: relevance, synthetic developments and biological significance"],"prefix":"10.1007","volume":"30","author":[{"given":"Aman","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Nisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Ekta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"11468_CR1","first-page":"1","volume-title":"Heterocyclic compounds: an introduction","author":"J \u00c1lvarez-Builla","year":"2011","unstructured":"\u00c1lvarez-Builla J, Barluenga J (2011) Heterocyclic compounds: an introduction. Wiley, Germany, pp 1\u20139"},{"key":"11468_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2022.100606","volume":"4","author":"E Kabir","year":"2022","unstructured":"Kabir E, Uzzaman M (2022) A review on biological and medicinal impact of heterocyclic compounds. Results Chem 4:100606. https:\/\/doi.org\/10.1016\/j.rechem.2022.100606","journal-title":"Results Chem"},{"key":"11468_CR3","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1039\/D5MD00403A","volume":"16","author":"M Ward","year":"2025","unstructured":"Ward M, O\u2019Boyle NM (2025) Analysis of the structural diversity of heterocycles amongst European medicines agency approved pharmaceuticals (2014\u20132023). Med Chem 16:4540\u20134570. https:\/\/doi.org\/10.1039\/D5MD00403A","journal-title":"Med Chem"},{"key":"11468_CR4","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/jhet.70013","volume":"62","author":"R Varala","year":"2025","unstructured":"Varala R, Mohan M, Kamsali A, Hussein M, Alam MM (2025) Visible light-mediated synthesis of quinazoline and quinazolinone derivatives: a quadrennial update. J Heterocycl Chem 62:848\u2013879. https:\/\/doi.org\/10.1002\/jhet.70013","journal-title":"J Heterocycl Chem"},{"key":"11468_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2023.136325","volume":"1294","author":"A Ghabi","year":"2023","unstructured":"Ghabi A, Mtiraoui H, Haouas A, Al-Ghulikah H, Sanselme M, Msaddek M (2023) Design and synthesis of new N-substituted benzimidazolidinone as predicted human BRD4 and human chymase inhibitors via molecular docking studies. J Mol Struct 1294:136325. https:\/\/doi.org\/10.1016\/j.molstruc.2023.136325","journal-title":"J Mol Struct"},{"key":"11468_CR6","doi-asserted-by":"publisher","first-page":"9764","DOI":"10.1021\/jm501105n","volume":"57","author":"BR Smith","year":"2014","unstructured":"Smith BR, Eastman CM, Njardarson JT (2014) Beyond C, H, O, and N! Analysis of the elemental composition of U.S. FDA approved drug architectures. J Med Chem 57:9764\u20139773. https:\/\/doi.org\/10.1021\/jm501105n","journal-title":"J Med Chem"},{"key":"11468_CR7","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.3390\/molecules29204810","volume":"29","author":"J Jampilek","year":"2024","unstructured":"Jampilek J (2024) Heterocycles in medicinal chemistry II. Molecules 29:4810. https:\/\/doi.org\/10.3390\/molecules29204810","journal-title":"Molecules"},{"key":"11468_CR8","doi-asserted-by":"publisher","first-page":"14599","DOI":"10.1080\/07391102.2023.2187640","volume":"41","author":"S Karthikeyan","year":"2023","unstructured":"Karthikeyan S, Grishina M, Kandasamy S, Mangaiyarkarasi R, Ramamoorthi A, Chinnathambi S, Pandian GN, Kennedy LJ (2023) A review on medicinally important heterocyclic compounds and importance of biophysical approach of underlying the insight mechanism in biological environment. Biomol Struct Dyn 41:14599\u201314619. https:\/\/doi.org\/10.1080\/07391102.2023.2187640","journal-title":"Biomol Struct Dyn"},{"key":"11468_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.104237","volume":"29","author":"P Shukla","year":"2024","unstructured":"Shukla P, Azad CS, Deswal D, Narula AN (2024) Revisiting the GBB reaction and redefining its relevance in medicinal chemistry: a review. Drug Discov Today 29:104237. https:\/\/doi.org\/10.1016\/j.drudis.2024.104237","journal-title":"Drug Discov Today"},{"key":"11468_CR10","doi-asserted-by":"publisher","first-page":"6611","DOI":"10.1039\/C6OB00936K","volume":"14","author":"AP Taylor","year":"2016","unstructured":"Taylor AP, Robinson RP, Fobian YM, Blakemore DC, Jones LH, Fadeyi O (2016) Modern advances in heterocyclic chemistry in drug discovery. Org Biomol Chem 14:6611\u20136637. https:\/\/doi.org\/10.1039\/C6OB00936K","journal-title":"Org Biomol Chem"},{"key":"11468_CR11","doi-asserted-by":"publisher","first-page":"770","DOI":"10.2174\/1389557521666210914124914","volume":"22","author":"T Sharma","year":"2022","unstructured":"Sharma T, Singh J, Singh B, Kataria R, Kumar V (2022) Methyl linked pyrazoles: synthetic and medicinal perspective. Mini-Rev Med Chem 22:770\u2013804. https:\/\/doi.org\/10.2174\/1389557521666210914124914","journal-title":"Mini-Rev Med Chem"},{"key":"11468_CR12","doi-asserted-by":"publisher","first-page":"5686","DOI":"10.3390\/molecules28155686","volume":"28","author":"A Fr\u00fchauf","year":"2023","unstructured":"Fr\u00fchauf A, Behringer M, Meyer-Almes FJ (2023) Significance of five-membered heterocycles in human histone deacetylase inhibitors. Molecules 28:5686. https:\/\/doi.org\/10.3390\/molecules28155686","journal-title":"Molecules"},{"key":"11468_CR13","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1080\/17415993.2025.2491527","volume":"46","author":"A Kumar","year":"2025","unstructured":"Kumar A, Sharma T, Jyoti SB, Kataria R, Singh J, Kumar V (2025) Exploring the synthetic developments and pharmacological potential of 2-amino\/hydrazino-4-arylthiazoles: a review. J Sulfur Chem 46:746\u2013793. https:\/\/doi.org\/10.1080\/17415993.2025.2491527","journal-title":"J Sulfur Chem"},{"key":"11468_CR14","doi-asserted-by":"publisher","first-page":"846","DOI":"10.2174\/138527210791111876","volume":"14","author":"KC Majumdar","year":"2010","unstructured":"Majumdar KC, Roy B, Debnath P, Taher A (2010) Metal-mediated heterocyclization: synthesis of heterocyclic compounds containing more than one heteroatom through carbon-heteroatom bond forming reactions. Curr Org Chem 14:846\u2013887. https:\/\/doi.org\/10.2174\/138527210791111876","journal-title":"Curr Org Chem"},{"key":"11468_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/org6010001","volume":"6","author":"O Baaloudj","year":"2025","unstructured":"Baaloudj O, Scrano L, Bufo SA, Modley L-AS, Lelario F, Zizzamia AR, Emanuele L, Brienza M (2025) Environmental fate, ecotoxicity, and remediation of heterocyclic pharmaceuticals as emerging contaminants: a review of long-term risks and impacts. Organics 6:1. https:\/\/doi.org\/10.3390\/org6010001","journal-title":"Organics"},{"key":"11468_CR16","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ejmech.2013.08.053","volume":"69","author":"V Kumar","year":"2013","unstructured":"Kumar V, Kaur K, Gupta GK, Sharma AK (2013) Pyrazole containing natural products: synthetic preview and biological significance. Eur J Med Chem 69:735\u2013753. https:\/\/doi.org\/10.1016\/j.ejmech.2013.08.053","journal-title":"Eur J Med Chem"},{"key":"11468_CR17","doi-asserted-by":"publisher","first-page":"143523","DOI":"10.1016\/j.molstruc.2025.143523","volume":"1348","author":"T Sarwar","year":"2025","unstructured":"Sarwar T, Mustafa G, Zafar W, Abrar Ul Hassan A, Sumrra HS, Asifet A (2025) Pyrazoles a privileged scaffold in drug discovery: synthetic strategies & exploration of pharmacological potential. J Mol Struct 1348:143523. https:\/\/doi.org\/10.1016\/j.molstruc.2025.143523","journal-title":"J Mol Struct"},{"key":"11468_CR18","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1002\/jhet.70065","volume":"62","author":"R Ramajayam","year":"2025","unstructured":"Ramajayam R (2025) A comprehensive review on traditional and modern synthetic approaches to pyrazole and its analogs. J Herocyclic Chem 62:1424\u20131462. https:\/\/doi.org\/10.1002\/jhet.70065","journal-title":"J Herocyclic Chem"},{"key":"11468_CR19","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1080\/10406638.2023.2181827","volume":"44","author":"S Patra","year":"2023","unstructured":"Patra S, Patra P (2023) A brief review on the design, synthesis and biological evaluation of pyrazolo[c]coumarin derivatives. PACs 44:818\u2013859. https:\/\/doi.org\/10.1080\/10406638.2023.2181827","journal-title":"PACs"},{"key":"11468_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202500767","volume":"10","author":"R Mukherjee","year":"2025","unstructured":"Mukherjee R, Saha I, Mitra P, Majhi S (2025) Nanoparticle-assisted green synthesis of n,n-heterocycles with anti-breast cancer activity: A decade of advances. ChemistrySelect 10:e00767. https:\/\/doi.org\/10.1002\/slct.202500767","journal-title":"ChemistrySelect"},{"key":"11468_CR21","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1016\/j.saa.2011.05.100","volume":"79","author":"V Krishnakumar","year":"2011","unstructured":"Krishnakumar V, Jayamani N, Mathammal R (2011) Molecular structure, vibrational spectral studies of pyrazole and 3,5-dimethyl pyrazole based on density functional calculations. Spectrochim Acta A Mol Biomol Spectrosc 79:1959\u20131968. https:\/\/doi.org\/10.1016\/j.saa.2011.05.100","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"11468_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3390\/ph16020299","volume":"16","author":"A Kumar","year":"2023","unstructured":"Kumar A, Singh AK, Singh H, Vijayan V, Kumar D, Naik J, Thareja S, Yadav JP, Pathak P, Grishina M, Verma A, Khalilullah H, Jaremko M, Emwas A-H, Kumar P (2023) Nitrogen-containing heterocycles as anticancer agents: a medicinal chemistry perspective. Pharmaceuticals 16:299. https:\/\/doi.org\/10.3390\/ph16020299","journal-title":"Pharmaceuticals"},{"key":"11468_CR23","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.ejmech.2003.11.002","volume":"39","author":"P Rani","year":"2004","unstructured":"Rani P, Srivastava VK, Kumar A (2004) Synthesis and antiinflammatory activity of heterocyclic indole derivatives. Eur J Med Chem 39:449\u2013452. https:\/\/doi.org\/10.1016\/j.ejmech.2003.11.002","journal-title":"Eur J Med Chem"},{"key":"11468_CR24","doi-asserted-by":"publisher","first-page":"858","DOI":"10.2174\/0115701794260444230925095804","volume":"21","author":"M Asif","year":"2024","unstructured":"Asif M, Almehmadi M, Alsaiari AA, Allahyani M (2024) Diverse pharmacological potential of different substituted pyrazole derivatives. Curr Org Synth 21:858\u2013888. https:\/\/doi.org\/10.2174\/0115701794260444230925095804","journal-title":"Curr Org Synth"},{"key":"11468_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10534-011-9496-4","volume":"25","author":"FK Keter","year":"2021","unstructured":"Keter FK, Darkwa J (2021) Perspective: the potential of pyrazole-based compounds in medicine. Biometals 25:9\u201321. https:\/\/doi.org\/10.1007\/s10534-011-9496-4","journal-title":"Biometals"},{"key":"11468_CR26","doi-asserted-by":"publisher","first-page":"12671","DOI":"10.1021\/acsomega.5c00320","volume":"10","author":"LV Ramoba","year":"2025","unstructured":"Ramoba LV, Nzondomyo WJ, Serala K, Macharia LW, Biswas S, Prince S, Malan FP, Alexander OT, Manicum A-LE (2025) Derivatives of pyrazole-based compounds as prospective cancer agents. ACS Omega 10:12671\u201312678. https:\/\/doi.org\/10.1021\/acsomega.5c00320","journal-title":"ACS Omega"},{"key":"11468_CR27","doi-asserted-by":"publisher","first-page":"7018","DOI":"10.1039\/D4RA08866B","volume":"15","author":"D Becerra","year":"2025","unstructured":"Becerra D, Castillo J-C (2025) Recent advances in the synthesis of anticancer pyrazole derivatives using microwave, ultrasound, and mechanochemical techniques. RSC Adv 15:7018\u20137038. https:\/\/doi.org\/10.1039\/D4RA08866B","journal-title":"RSC Adv"},{"key":"11468_CR28","doi-asserted-by":"publisher","first-page":"12724","DOI":"10.3390\/ijms241612724","volume":"24","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Wu C, Zhang N, Fan R, Ye Y, Xu J (2023) Recent advances in the development of pyrazole derivatives as anticancer agents. Int J Mol Sci 24:12724. https:\/\/doi.org\/10.3390\/ijms241612724","journal-title":"Int J Mol Sci"},{"key":"11468_CR29","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1080\/14756366.2020.1742116","volume":"35","author":"SA Ali","year":"2020","unstructured":"Ali SA, Awad SM, Said AM, Mahgoub S, Taha H, Ahmed NM (2020) Design, synthesis, molecular modelling and biological evaluation of novel 3-(2-naphthyl)-1-phenyl-1H-pyrazole derivatives as potent antioxidants and 15-Lipoxygenase inhibitors. J Enzyme Inhib Med Chem 35:847\u2013863. https:\/\/doi.org\/10.1080\/14756366.2020.1742116","journal-title":"J Enzyme Inhib Med Chem"},{"key":"11468_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-03495-6","volume":"15","author":"A El-Sewedy","year":"2025","unstructured":"El-Sewedy A, Morsy ARI, El-Bordany EA et al (2025) Antiviral activity of newly synthesized pyrazole derivatives against Newcastle disease virus. Sci Rep 15:18745. https:\/\/doi.org\/10.1038\/s41598-025-03495-6","journal-title":"Sci Rep"},{"key":"11468_CR31","doi-asserted-by":"publisher","first-page":"27935","DOI":"10.1039\/D4RA04728A","volume":"14","author":"ARI Morsy","year":"2024","unstructured":"Morsy ARI, Mahmoud SH, Shama NMA, Arafa W, Yousef GA, Khalil AA, Ramadan SK (2024) Antiviral activity of pyrazole derivatives bearing a hydroxyquinoline scaffold against SARS-CoV-2, HCoV-229E, MERS-CoV, and IBV propagation. RSC Adv 14:27935\u201327947. https:\/\/doi.org\/10.1039\/D4RA04728A","journal-title":"RSC Adv"},{"key":"11468_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.117081","volume":"282","author":"MU Rehman","year":"2025","unstructured":"Rehman MU, He F, Shu X, Guo J, Liu Z, Cao S, Long S (2025) Antibacterial and antifungal pyrazoles based on different construction strategies. Eur J Med Chem 282:117081. https:\/\/doi.org\/10.1016\/j.ejmech.2024.117081","journal-title":"Eur J Med Chem"},{"key":"11468_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065319","volume":"24","author":"A Burke","year":"2023","unstructured":"Burke A, Di Filippo M, Spiccio S, Schito AM, Caviglia D, Brullo C, Baumann M (2023) Antimicrobial evaluation of new pyrazoles, indazoles and pyrazolines prepared in continuous flow mode. Int J Mol Sci 24:5319. https:\/\/doi.org\/10.3390\/ijms24065319","journal-title":"Int J Mol Sci"},{"key":"11468_CR34","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1016\/j.bmc.2006.02.046","volume":"14","author":"P Singh","year":"2006","unstructured":"Singh P, Paul K, Holzer W (2006) Synthesis of pyrazole-based hybrid molecules: search for potent multidrug resistance modulators. Bioorg Med Chem 14:5061\u20135071. https:\/\/doi.org\/10.1016\/j.bmc.2006.02.046","journal-title":"Bioorg Med Chem"},{"key":"11468_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s12039-019-1646-1","volume":"131","author":"M Faisal","year":"2019","unstructured":"Faisal M, Saeed A, Hussain S et al (2019) Recent developments in synthetic chemistry and biological activities of pyrazole derivatives. J Chem Sci 131:70. https:\/\/doi.org\/10.1007\/s12039-019-1646-1","journal-title":"J Chem Sci"},{"key":"11468_CR36","doi-asserted-by":"publisher","first-page":"8575","DOI":"10.1039\/C9CC04012A","volume":"55","author":"T Morofuji","year":"2019","unstructured":"Morofuji T, Kinoshita H, Kano N (2019) Connecting a carbonyl and a \u03c0-conjugated group through a p-phenylene linker by (5+1) benzene ring formation. Chem Commun 55:8575\u20138578. https:\/\/doi.org\/10.1039\/C9CC04012A","journal-title":"Chem Commun"},{"key":"11468_CR37","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1007\/s00044-015-1467-9","volume":"24","author":"PS Nayak","year":"2015","unstructured":"Nayak PS, Narayana B, Sarojini BK, Fernades J, Bharath BR, Madhu LN (2015) Synthesis, molecular docking and biological evaluation of novel bis-pyrazole derivatives for analgesic, anti-inflammatory and antimicrobial activities. Med Chem Res 24:4191\u20134206. https:\/\/doi.org\/10.1007\/s00044-015-1467-9","journal-title":"Med Chem Res"},{"key":"11468_CR38","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.arabjc.2013.07.019","volume":"10","author":"HB Mehta","year":"2017","unstructured":"Mehta HB, Patel PK, Dixit BC, Dixit RB (2017) Synthesis and antimicrobial activities of new mono and bisphenyl linked bispyrazole and bispyrazolone derivatives. Arab J Chem 10:1901\u20131912. https:\/\/doi.org\/10.1016\/j.arabjc.2013.07.019","journal-title":"Arab J Chem"},{"key":"11468_CR39","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.jare.2016.09.001","volume":"7","author":"AS Shawali","year":"2016","unstructured":"Shawali AS (2016) A review on bis-hydrazonoyl halides: recent advances in their synthesis and their diverse synthetic applications leading to bis-heterocycles of biological interest. J Adv Res 7:873\u2013907. https:\/\/doi.org\/10.1016\/j.jare.2016.09.001","journal-title":"J Adv Res"},{"key":"11468_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1021\/co400133a","volume":"16","author":"S Murru","year":"2014","unstructured":"Murru S, Nefzi A (2014) Combinatorial synthesis of oxazol-thiazole bis-heterocyclic compounds. ACS Comb Sci 16:39\u201345. https:\/\/doi.org\/10.1021\/co400133a","journal-title":"ACS Comb Sci"},{"key":"11468_CR41","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.2174\/1389557519666190313095545","volume":"19","author":"ZA Muhammad","year":"2019","unstructured":"Muhammad ZA, Alshehrei F, Zayed MEM, Farghaly TA, Abdallah MA (2019) Synthesis of novel bis-pyrazole derivatives as antimicrobial agents. Mini-Rev Med Chem 19:1276\u20131290. https:\/\/doi.org\/10.2174\/1389557519666190313095545","journal-title":"Mini-Rev Med Chem"},{"key":"11468_CR42","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1039\/C6CS00368K","volume":"46","author":"Z Yang","year":"2017","unstructured":"Yang Z, Mao Z, Xie Z, Zhang Y, Liu S, Zhao J, Xu J, Chi Z, Aldred MP (2017) Recent advances in organic thermally activated delayed fluorescence materials. Chem Soc Rev 46:915\u20131016. https:\/\/doi.org\/10.1039\/C6CS00368K","journal-title":"Chem Soc Rev"},{"key":"11468_CR43","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1021\/cr970027+","volume":"106","author":"G Wenz","year":"2006","unstructured":"Wenz G, Han B-H, M\u00fcller A (2006) Cyclodextrin rotaxanes and polyrotaxanes. Chem Rev 106:782\u2013817. https:\/\/doi.org\/10.1021\/cr970027+","journal-title":"Chem Rev"},{"key":"11468_CR44","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1039\/C7CS00163K","volume":"46","author":"DB Amabilino","year":"2017","unstructured":"Amabilino DB, Smith DK, Steed JW (2017) Supramolecular materials. Chem Soc Rev 46:2404\u20132420. https:\/\/doi.org\/10.1039\/C7CS00163K","journal-title":"Chem Soc Rev"},{"key":"11468_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/9783527665211","volume-title":"Gemma S (2014) Structure-based design of drugs and other bioactive molecules: tools and strategies","author":"AK Ghosh","year":"2014","unstructured":"Ghosh AK (2014) Gemma S (2014) Structure-based design of drugs and other bioactive molecules: tools and strategies. Wiley, New York"},{"key":"11468_CR46","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/cmdc.202000824","volume":"16","author":"B Venteicher","year":"2021","unstructured":"Venteicher B, Merklin K, Ngo HX et al (2021) The effects of prodrug size and a carbonyl linker on l-Type amino acid transporter 1-targeted cellular and brain uptake. ChemMedChem 16:869\u2013880. https:\/\/doi.org\/10.1002\/cmdc.202000824","journal-title":"ChemMedChem"},{"key":"11468_CR47","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.1021\/acs.joc.9b00282","volume":"84","author":"T Dai","year":"2019","unstructured":"Dai T, Li Q, Zhang X, Yang C (2019) Substituent-oriented synthesis of substituted pyrazoles\/chromeno[3,2-c]pyrazoles via sequential reactions of chromones\/3-chlorochromones and tosylhydrazones. J Org Chem 84:5913\u20135921. https:\/\/doi.org\/10.1021\/acs.joc.9b00282","journal-title":"J Org Chem"},{"key":"11468_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/cddiscovery.2015.9","volume":"1","author":"S Berger","year":"2015","unstructured":"Berger S, Harris P, Nagilla R et al (2015) Characterization of GSK\u2032963: a structurally distinct, potent and selective inhibitor of RIP1 kinase. Cell Death Discov 1:15009. https:\/\/doi.org\/10.1038\/cddiscovery.2015.9","journal-title":"Cell Death Discov"},{"key":"11468_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-024-05086-z","volume":"19","author":"L Wen","year":"2024","unstructured":"Wen L, Chen C, Deng Y et al (2024) Effectiveness of indomethacin in preventing heterotopic ossification: a systematic review and meta-analysis of randomized controlled trials. J Orthop Surg Res 19:589. https:\/\/doi.org\/10.1186\/s13018-024-05086-z","journal-title":"J Orthop Surg Res"},{"key":"11468_CR50","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.canlet.2015.10.025","volume":"370","author":"R Ju","year":"2016","unstructured":"Ju R, Guo L, Li J, Zhu L, Yu X, Chen C, Chen W, Ye C, Zhang D (2016) Carboxyamidotriazole inhibits oxidative phosphorylation in cancer cells and exerts synergistic anti-cancer effect with glycolysis inhibition. Cancer Lett 370:232\u2013241. https:\/\/doi.org\/10.1016\/j.canlet.2015.10.025","journal-title":"Cancer Lett"},{"key":"11468_CR51","doi-asserted-by":"publisher","DOI":"10.1177\/20406207211066070","author":"A-S Hanny","year":"2021","unstructured":"Hanny A-S, van Beers EJ (2021) Mitapivat, a novel pyruvate kinase activator, for the treatment of hereditary hemolytic anemias. Ther Adv Hematol. https:\/\/doi.org\/10.1177\/20406207211066070","journal-title":"Ther Adv Hematol"},{"key":"11468_CR52","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s40265-022-01699-y","volume":"82","author":"A Markham","year":"2022","unstructured":"Markham A (2022) Daridorexant: first approval. Drugs 82:601\u2013607. https:\/\/doi.org\/10.1007\/s40265-022-01699-y","journal-title":"Drugs"},{"key":"11468_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.140169","volume":"1321","author":"S Singh","year":"2025","unstructured":"Singh S, Tahlan S, Singh K, Verma PK (2025) Design, synthesis, and biological evaluation of novel bis-pyrazole derivatives: a unified in silico and experimental methodology. J Mol Struct 1321:140169. https:\/\/doi.org\/10.1016\/j.molstruc.2024.140169","journal-title":"J Mol Struct"},{"key":"11468_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103540","volume":"95","author":"KRA Abdellatif","year":"2020","unstructured":"Abdellatif KRA, Abdelall EKA, Lamie PF, Labib MB, El-Nahaas S, Abdelhakeem MM (2020) New pyrazole derivatives possessing amino\/methanesulphonyl pharmacophore with good gastric safety profile: design, synthesis, cyclooxygenase inhibition, anti-inflammatory activity and histopathological studies. Bioorg Chem 95:103540. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103540","journal-title":"Bioorg Chem"},{"key":"11468_CR55","doi-asserted-by":"publisher","first-page":"135780","DOI":"10.1016\/j.molstruc.2023.135780","volume":"1289","author":"S Anjali","year":"2023","unstructured":"Anjali S, Sangeetha M, Nithya M, Krishnan GV, Varughese S, Kumar D et al (2023) Pyrazole appended hetero-hybrids: Bioisosteric design, synthesis, in silico and in vitro antibacterial and anti-inflammatory evaluations. J Mol Struct 1289:135780\u2013135780. https:\/\/doi.org\/10.1016\/j.molstruc.2023.135780","journal-title":"J Mol Struct"},{"key":"11468_CR56","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/cjoc.20040220936","volume":"22","author":"M Li","year":"2004","unstructured":"Li M, Wen L-R, Fu WJ, Zhao G-L, Hu F-Z, Yang H-Z (2004) Reaction of ketene dithioacetals with pyrazolylcarbohydrazide: synthesis and biological activities of ethyl 5-amino-1-(5\u2019-methyl-1\u2019-t-butyl-4\u2019-pyrazolyl)carbonyl-3-methylthio-1H-pyrazole-4-carboxylate. Chin J Chem 22:1064\u20131066. https:\/\/doi.org\/10.1002\/cjoc.20040220936","journal-title":"Chin J Chem"},{"key":"11468_CR57","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00706-015-1549-x","volume":"147","author":"A Ashour","year":"2015","unstructured":"Ashour A, El-Ashmawy IM, Bayad AE (2015) Synthesis and pharmacological evaluation of new pyrazolyl benzenesulfonamides linked to polysubstituted pyrazoles and thiazolidinones as anti-inflammatory and analgesic agents. Monatsh Chem 147:605\u2013618. https:\/\/doi.org\/10.1007\/s00706-015-1549-x","journal-title":"Monatsh Chem"},{"key":"11468_CR58","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/jhet.1724","volume":"51","author":"AH Shamroukh","year":"2013","unstructured":"Shamroukh AH, Rashad AE, Ali HS, Awad SM (2013) Studies on the reactivity of amino-1-(6-phenyl-pyridazin-3-yl)-1H-pyrazole-4-carboxylic acid hydrazide towards some reagents for biological evaluation. J Heterocycl Chem 51:899\u2013905. https:\/\/doi.org\/10.1002\/jhet.1724","journal-title":"J Heterocycl Chem"},{"key":"11468_CR59","volume":"5","author":"KB Umesha","year":"2009","unstructured":"Umesha KB, Rai KML, Nayaka MAH (2009) Antioxidant and antimicrobial activity of 5-methyl-2-(5-methyl-1,3-diphenyl-1H-pyrazole-4-carbonyl)-2,4-dihydro-pyrazol-3-one. Int J Biomed Sci 5:4","journal-title":"Int J Biomed Sci"},{"key":"11468_CR60","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1080\/10406638.2020.1764984","volume":"40","author":"AY Hassan","year":"2020","unstructured":"Hassan AY, Mohamed MA, Abdel-Aziem A, Hussain AO (2020) Synthesis and anticancer activity of some fused heterocyclic compounds containing pyrazole ring. PAH 40:1280\u20131290. https:\/\/doi.org\/10.1080\/10406638.2020.1764984","journal-title":"PAH"},{"key":"11468_CR61","first-page":"1193","volume":"72","author":"KA Ali","year":"2015","unstructured":"Ali KA, Elsayed MA, Elhallouty SM, Mahmoud K, Farag AM (2015) Synthesis and antitumor screening of some new 2,6-bispyridines functionalized with pyrazole-based heterocycles. Acta Pol Pharm 72:1193\u20131200","journal-title":"Acta Pol Pharm"},{"key":"11468_CR62","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1515\/HC.2005.11.3-4.255","volume":"11","author":"AA Farghaly","year":"2005","unstructured":"Farghaly AA, Vanelle P, El-Kashe HS (2005) Synthesis, reactions and antimicrobial activity of some new 1,3,4 oxadiazoles, 1,2,4-triazoles and 1,3,4-thiadiazines derived from pyrazole. Heterocycl Commun 11:3\u20134. https:\/\/doi.org\/10.1515\/HC.2005.11.3-4.255","journal-title":"Heterocycl Commun"},{"key":"11468_CR63","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1081\/scc-120027248","volume":"34","author":"Y Liu","year":"2004","unstructured":"Liu Y, Zhang X, Ren J, Jin G (2004) Convenient preparation of novel fused tri\u2010heterocyclic compounds. Synth Commun 34:151\u2013157. https:\/\/doi.org\/10.1081\/scc-120027248","journal-title":"Synth Commun"},{"key":"11468_CR64","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/jhet.2644","volume":"54","author":"TA Farghaly","year":"2016","unstructured":"Farghaly TA, Abdallah MA, Abdel MR (2016) Synthesis of a novel tri-enaminone as building block for polyaza-heterocycles. J Heterocycl Chem 54:699\u2013705. https:\/\/doi.org\/10.1002\/jhet.2644","journal-title":"J Heterocycl Chem"},{"key":"11468_CR65","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/jhet.840","volume":"50","author":"AS Shawali","year":"2013","unstructured":"Shawali AS, Haboub AJM (2013) Reaction of hydrazonoyl halides with bis-enaminones: a convenient route for synthesis of novel polyaza-terheterocycles. J Heterocycl Chem 50:17\u201322. https:\/\/doi.org\/10.1002\/jhet.840","journal-title":"J Heterocycl Chem"},{"key":"11468_CR66","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.1016\/j.ejmech.2010.09.054","volume":"45","author":"AM Farag","year":"2010","unstructured":"Farag AM, Korany AKA, Taha MAE-D, Mayhoub AS, Amr A-GE, Abdel-Hafez NA, Abdulla MM (2010) Design, synthesis and structure\u2013activity relationship study of novel pyrazole-based heterocycles as potential antitumor agents. Eur J Med Chem 45:5887\u20135898. https:\/\/doi.org\/10.1016\/j.ejmech.2010.09.054","journal-title":"Eur J Med Chem"},{"key":"11468_CR67","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.ejmech.2009.11.050","volume":"45","author":"SM Riyadh","year":"2009","unstructured":"Riyadh SM, Farghaly TA, Abdallah MA, Abdalla MM, Abd MR (2009) New pyrazoles incorporating pyrazolylpyrazole moiety: synthesis, anti-HCV and antitumor activity. Eur J Med Chem 45:1042\u20131050. https:\/\/doi.org\/10.1016\/j.ejmech.2009.11.050","journal-title":"Eur J Med Chem"},{"key":"11468_CR68","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/jhet.113","volume":"46","author":"AS Shawali","year":"2009","unstructured":"Shawali AS, Sherif SM, El-Merzabani MM, Darwish MAA (2009) Synthesis and antitumor activity of novel pyrazolylenaminone and bis(pyrazolyl)ketones via hydrazonoyl halides. J Heterocycl Chem 46:548\u2013551. https:\/\/doi.org\/10.1002\/jhet.113","journal-title":"J Heterocycl Chem"},{"key":"11468_CR69","first-page":"88","volume":"xiv","author":"AS Shawali","year":"2009","unstructured":"Shawali AS, Farghaly TA, Al-Dahshoury AR (2009) Synthesis, reactions and antitumor activity of new \u03b2-aminovinyl 3-pyrazolyl ketones. ARKIVOC xiv:88\u201399","journal-title":"ARKIVOC"},{"key":"11468_CR70","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/jhet.4833","volume":"61","author":"MG Kamel","year":"2024","unstructured":"Kamel MG, Helmy MT, Saleh FM, Hassaneen HM, Shehata OA, Laboud YN (2024) Convenient synthesis and antibacterial evaluation of new bipyrazolyl and pyrazolopyridazine derivatives utilizing 4-acetyl-5-methyl-N-phenyl-1-(p-tolyl)-1H-pyrazole-3-carboxamide as a versatile precursor. J Heterocycl Chem 61:1150\u20131158. https:\/\/doi.org\/10.1002\/jhet.4833","journal-title":"J Heterocycl Chem"},{"key":"11468_CR71","doi-asserted-by":"publisher","first-page":"6106","DOI":"10.3390\/molecules15096106","volume":"15","author":"B Datterl","year":"2010","unstructured":"Datterl B, Tr\u00f6stner N, Kucharski D, Holzer W (2010) Heterocyclic analogues of xanthone and xanthione. 1H-pyrano[2,3-c:6,5-c]dipyrazol-4(7H)-ones and thiones: synthesis and NMR data. Molecules 15:6106\u20136126. https:\/\/doi.org\/10.3390\/molecules15096106","journal-title":"Molecules"},{"key":"11468_CR72","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1007\/s11172-006-0199-x","volume":"54","author":"VY Sosnovskikh","year":"2005","unstructured":"Sosnovskikh VY, Barabanov MA, Usachev BI, Irgashev RA, Moshkin VS (2005) Synthesis and some properties of 6-di(tri)fluoromethyl- and 5-di(tri)fluoroacetyl-3-methyl-1-phenylpyrano[2,3-c]pyrazol-4(1H)-ones. Russ Chem Bull 54:2846\u20132850","journal-title":"Russ Chem Bull"},{"key":"11468_CR73","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1002\/jhet.5570450627","volume":"45","author":"MR Shaaban","year":"2009","unstructured":"Shaaban MR, Eldebss TMA, Darweesh AF, Farag AM (2009) Synthesis of novel pyrazolo[3,4-d]pyridazine, pyrido[1,2-a]benzimidazole, pyrimido[1,2-a]benzimidazole and triazolo[4,3-a]pyrimidine derivatives. J Heterocycl Chem 45:1739. https:\/\/doi.org\/10.1002\/jhet.5570450627","journal-title":"J Heterocycl Chem"},{"key":"11468_CR74","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1080\/10406638.2023.2214284","volume":"44","author":"MT Helmy","year":"2023","unstructured":"Helmy MT, Sroor FM, Hassaneen HM, Mohamed Teleb MA, Saleh FM (2023) Synthesis of novel pyrazolyl and isoxazolyl 3-(furan-2-yl)-5-methyl-1-(4-nitrophenyl)-1H-pyrazol-4-yl derivatives via regioselectivity of the 1,3-dipolar cycloaddition. Polycycl Aromat Compd 44:2212\u20132225. https:\/\/doi.org\/10.1080\/10406638.2023.2214284","journal-title":"Polycycl Aromat Compd"},{"key":"11468_CR75","doi-asserted-by":"publisher","first-page":"135722","DOI":"10.1016\/j.molstruc.2023.135722","volume":"1287","author":"MG Kamel","year":"2023","unstructured":"Kamel MG, Hassaneen HM, Sroor FM, Abdallah TA, Mohamed MA, Saleh FM (2023) Novel bipyrazole and pyrazolopyridazinone derivatives via regioselective cycloaddition reaction of nitrilimines to enaminone: synthesis and structural elucidation. J Mol Struct 1287:135722\u2013135722. https:\/\/doi.org\/10.1016\/j.molstruc.2023.135722","journal-title":"J Mol Struct"},{"key":"11468_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-017-0266-4","volume":"11","author":"SM Gomha","year":"2017","unstructured":"Gomha SM, Edrees MM, Faty RAM, Muhammad ZA, Mabkhot YN (2017) Microwave-assisted one pot three-component synthesis of some novel pyrazole scaffolds as potent anticancer agents. Chem Cent J 11:37. https:\/\/doi.org\/10.1186\/s13065-017-0266-4","journal-title":"Chem Cent J"},{"key":"11468_CR77","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.bmc.2007.10.015","volume":"16","author":"AM Farag","year":"2008","unstructured":"Farag AM, Mayhoub AS, Barakat SE, Bayomi AH (2008) Regioselective synthesis and antitumor screening of some novel N-phenylpyrazole derivatives. Bioorg Med Chem 16:881\u2013889. https:\/\/doi.org\/10.1016\/j.bmc.2007.10.015","journal-title":"Bioorg Med Chem"},{"key":"11468_CR78","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1007\/s00044-017-2002-y","volume":"26","author":"G Mondal","year":"2017","unstructured":"Mondal G, Jana H, Moumita A, Ananyakumari S, Bera P et al (2017) Synthesis, in vitro evaluation of antibacterial, antifungal and larvicidal activities of pyrazole\/pyridine based compounds and their nanocrystalline MS (M = Cu and Cd) derivatives. Med Chem Res 26:3046\u20133056. https:\/\/doi.org\/10.1007\/s00044-017-2002-y","journal-title":"Med Chem Res"},{"key":"11468_CR79","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/ardp.200900176","volume":"343","author":"AM Farag","year":"2010","unstructured":"Farag AM, Mayhoub AS, Eldebss TMA, Amr A-GE, Ali KAK, Abdel-Hafez NA, Abdulla MM (2010) Synthesis and structure-activity relationship studies of pyrazole-based heterocycles as antitumor agents. Arch Pharm (Weinheim) 343:384\u2013396. https:\/\/doi.org\/10.1002\/ardp.200900176","journal-title":"Arch Pharm (Weinheim)"},{"key":"11468_CR80","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1016\/j.bmc.2010.02.006","volume":"18","author":"SAF Rostom","year":"2010","unstructured":"Rostom SAF (2010) Polysubstituted pyrazoles, part 6. Synthesis of some 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazol-3-carbonyl derivatives linked to nitrogenous heterocyclic ring systems as potential antitumor agents. Bioorg Med Chem 18:2767\u20132776. https:\/\/doi.org\/10.1016\/j.bmc.2010.02.006","journal-title":"Bioorg Med Chem"},{"key":"11468_CR81","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/j.bmcl.2016.03.117","volume":"26","author":"HN Hafez","year":"2016","unstructured":"Hafez HN, El-Gazzar A-RBA, Al-Hussain SA (2016) Novel pyrazole derivatives with oxa\/thiadiazolyl, pyrazolyl moieties and pyrazolo[4,3-d]-pyrimidine derivatives as potential antimicrobial and anticancer agents. Bioorg Med Chem Lett 26:2428\u20132433. https:\/\/doi.org\/10.1016\/j.bmcl.2016.03.117","journal-title":"Bioorg Med Chem Lett"},{"key":"11468_CR82","first-page":"248","volume":"66","author":"NJ Siddiquia","year":"2013","unstructured":"Siddiquia NJ, Idreesa M, Khatib NT, Dhonde MG (2013) Synthesis and antimicrobial activities of some new pyrazoles, oxadiazoles and isoxazole bearing benzofuran moiety. S Afr J Chem 66:248\u2013253","journal-title":"S Afr J Chem"},{"key":"11468_CR83","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/ardp.200800119","volume":"341","author":"BF Abdel-Wahab","year":"2008","unstructured":"Abdel-Wahab BF, Abdel-Aziz HA, Ahmed EM (2008) Convenient synthesis and antimicrobial activity of new 3-substituted 5-(benzofuran-2-yl)-pyrazole derivatives. Arch Pharm Chem Life Sci 341:734\u2013739. https:\/\/doi.org\/10.1002\/ardp.200800119","journal-title":"Arch Pharm Chem Life Sci"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11468-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11468-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11468-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:40:05Z","timestamp":1783161605000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11468-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":83,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["11468"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11468-8","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}